Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-23-000134

← back to feed
Filed
May 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 3, 2023 708K sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $4.94K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $163
Current Liabilities Q1 2023 · Mar 31, 2023 $427.06K
Current Liabilities Q1 2023 · Dec 31, 2022 $411.5K
Total Liabilities Q1 2023 · Mar 31, 2023 $427.06K
Total Liabilities Q1 2023 · Dec 31, 2022 $411.5K
Current Assets Q1 2023 · Mar 31, 2023 $4.94K
Current Assets Q1 2023 · Dec 31, 2022 $163
Total Assets Q1 2023 · Mar 31, 2023 $4.94K
Total Assets Q1 2023 · Dec 31, 2022 $163
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$5.11K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$388.04K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$377.59K
Sga Expense Q1 2023 · Mar 31, 2022 $5.61K
Net Income Q1 2023 · Mar 31, 2022 −$10.45K
Operating Income Q1 2023 · Mar 31, 2022 −$5.61K